Higher Body Fat Linked to Higher Risk of Death From Prostate Cancer
Increases in waist-to-hip ratio, body mass index, waist circumference, and total body fat percentage were associated with increases in the risk of prostate cancer death.
Increases in waist-to-hip ratio, body mass index, waist circumference, and total body fat percentage were associated with increases in the risk of prostate cancer death.
The risk of dying from a subsequent primary cancer remained significantly elevated for 20 years or more for some patients.
Younger patients with cancer are “a high-risk population for poor outcomes from COVID-19,” according to researchers.
A meta-analysis showed a significant improvement in overall survival, but not disease-free survival, with laparoscopic surgery.
Nearly 70% of patients had at least 1 potentially actionable therapeutic target.
Adding adebrelimab to chemotherapy nearly doubled the 2-year overall survival rate and more than tripled the 1-year progression-free survival rate.
Pediatric cancer patients in low- and middle-income countries had a nearly 16-fold higher risk of all-cause mortality within 30 days of presentation, when compared with their counterparts in high-income countries.
In the year before the RACE Act was implemented, none of the approved therapies required pediatric study, but 92% of them had a mechanism of action that would necessitate pediatric studies under the RACE Act.
Patients who received treatment selected by the ChemoID assay had superior progression-free survival and overall survival.
AI models could enable earlier detection of pancreatic cancer and improve treatment options for patients, according to researchers.